Dementia News and Research

Latest Dementia News and Research

Neuroscientist from DZNE wins 1.3M Euros to explore how spatial orientation changes in elderly humans

Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.

23 Aug 2013

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

New research suggests that chronic traumatic encephalopathy, a brain disease associated with repeat brain trauma including concussions in athletes, may affect people in two major ways: initially affecting behavior or mood or initially affecting memory and thinking abilities.

22 Aug 2013

LBDA creates two LBD symptom checklists for physicians and patients

The Lewy Body Dementia Association announced today the launch of new resources for physicians and their patients. LBDA created two new LBD symptom checklists; an abbreviated checklist to assist in the reporting of LBD diagnostic symptoms and a more comprehensive checklist to help people already diagnosed with LBD or their caregivers to report new or concerning LBD symptoms as the disease progresses.

22 Aug 2013

Study shows ERs are not meeting needs of senior citizens

Emergency departments are not meeting the needs of senior citizens, according to a new international study published in the Annals of Emergency Medicine.

21 Aug 2013

Researchers develop simple scoring system to predict risk of dementia in older diabetes patients

Researchers have developed a simple scoring system, based on a patient’s age, health issues, and education, which accurately predicts the risk of dementia in people aged over 60 with type 2 diabetes.

20 Aug 2013

D-Pharm announces promising results with drug candidates in models of HAT and malaria

D-Pharm Ltd., announced today on-line publication of promising results with its drug candidates, DP-460 and DP-b99, in models of human African trypanosomiasis (HAT) and malaria.

20 Aug 2013

Researchers study connections between brain network damage and Alzheimer's disease

In patients with early Alzheimer's disease, disruptions in brain networks emerge about the same time as chemical markers of the disease appear in the spinal fluid, researchers at Washington University School of Medicine in St. Louis have shown.

20 Aug 2013

Medical decision making for family member of cognitively impaired patient is more complicated

Decision-making by a surrogate for a family member who is unable to make medical decisions is more complicated than decision-making by patients themselves, according to a study from the Regenstrief Institute, Indiana University Center for Aging Research and the Charles Warren Fairbanks Center for Medical Ethics of Indiana University Health.

19 Aug 2013

Kinetin stops the effects of Parkinson's disease on brain cells, say scientists

The active ingredient in an over-the-counter skin cream might do more than prevent wrinkles. Scientists have discovered that the drug, called kinetin, also slows or stops the effects of Parkinson's disease on brain cells.

16 Aug 2013

Novel potential biomarker present in CSF reveals signs of dementia decade before

A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.

16 Aug 2013

MOOCs courses offered by JHUSON concentrate on Dementia and TB

An aging population and an old health scourge are the driving forces behind two massive open online courses (MOOCs) being offered this fall by the Johns Hopkins University School of Nursing (JHUSON).

14 Aug 2013

Nine risk factors for YOD in late adolescence

A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.

13 Aug 2013

New research opens door for development of treatments capable of stopping Alzheimer's disease

New research just out in the journal Science Translational Medicine opens the door for the development of treatments capable of stopping Alzheimer's disease (AD) before its first symptoms, that is to say before any crucial damage occurs. In fact, if AD is a devastating disorder it is also an extremely slow one; it takes more than 10 years for the first symptoms to appear making this preclinical period (pre-symptoms) the ideal time to intervene.

13 Aug 2013

Cedars-Sinai launches Phase I clinical trial to study tolerability of immunization to treat Alzheimer's disease

Cedars-Sinai Medical Center has launched a Phase I clinical trial to study the safety and tolerability of an experimental immunization to treat Alzheimer's disease. The treatment is based on Copaxone (glatiramer acetate), a drug often prescribed to reduce the frequency of multiple sclerosis relapses.

13 Aug 2013

Simple tests to recognize ability of famous people may help doctors identify early dementia

A new study suggests that simple tests that measure the ability to recognize and name famous people such as Albert Einstein, Bill Gates or Oprah Winfrey may help doctors identify early dementia in those 40 to 65 years of age.

13 Aug 2013

QUM report helps manage antipsychotic medicine use in residential aged care facilities

NPS MedicineWise and Webstercare have collaborated for the first time on a project to assist in the review of antipsychotic medicine use in residential aged care facilities.

12 Aug 2013

Congress weighing changes to Medicare reimbursements for doctors

In other Medicare news, USA Today looks at the debate over whether the government should pay for Alzheimer's PET scans.

12 Aug 2013

L-3-n-butylphthalide is potentially beneficial drug for treatment of vascular dementia

3-N-butylphthalide, a green botanical medicine, is a successfully synthesized and stable chemical drug used for the treatment of ischemic stroke that has independent intellectual property rights in China.

12 Aug 2013

Frontotemporal dementia (FTD) and emotional memories: an interview with Dr. Fiona Kumfor and Assoc. Prof. Olivier Piguet, NeuRA

Frontotemporal dementia (FTD) is a progressive neurodegenerative brain disorder, which affects the frontal and temporal lobes. Unlike other types of dementia, it more commonly occurs in individuals in their 50s and 60s, and is therefore referred to as a “younger-onset dementia”.

9 Aug 2013

First Edition: August 9, 2013

Today's early morning highlights from the major news organizations, including Kathleen Sebelius' outreach to Texans and a look at Americans' comprehension of health insurance.

9 Aug 2013

Dementia News and Research

Latest Dementia News and Research

Neuroscientist from DZNE wins 1.3M Euros to explore how spatial orientation changes in elderly humans

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

LBDA creates two LBD symptom checklists for physicians and patients

Study shows ERs are not meeting needs of senior citizens

Researchers develop simple scoring system to predict risk of dementia in older diabetes patients

D-Pharm announces promising results with drug candidates in models of HAT and malaria

Researchers study connections between brain network damage and Alzheimer's disease

Medical decision making for family member of cognitively impaired patient is more complicated

Kinetin stops the effects of Parkinson's disease on brain cells, say scientists

Novel potential biomarker present in CSF reveals signs of dementia decade before

MOOCs courses offered by JHUSON concentrate on Dementia and TB

Nine risk factors for YOD in late adolescence

New research opens door for development of treatments capable of stopping Alzheimer's disease

Cedars-Sinai launches Phase I clinical trial to study tolerability of immunization to treat Alzheimer's disease

Simple tests to recognize ability of famous people may help doctors identify early dementia

QUM report helps manage antipsychotic medicine use in residential aged care facilities

Congress weighing changes to Medicare reimbursements for doctors

L-3-n-butylphthalide is potentially beneficial drug for treatment of vascular dementia

Frontotemporal dementia (FTD) and emotional memories: an interview with Dr. Fiona Kumfor and Assoc. Prof. Olivier Piguet, NeuRA

First Edition: August 9, 2013

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Dementia News and Research

Latest Dementia News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in